Publications by Maha M Al Qahtani

Publications by authors named "Maha M Al Qahtani"

Page 1 of 1

Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.

Ohoud Aljuhani Ghazwa B Korayem Ali F Altebainawi Abdullah Al Harthi Hisham A Badreldin Maha M AlQahtani

J Intensive Care Med

June 2023

Article Synopsis

Tocilizumab (TCZ) may be an effective early treatment for critically ill COVID-19 patients, as it shows potential in reducing multiorgan dysfunction compared to standard care.
A multicenter cohort study analyzed 300 ICU patients, revealing those who received TCZ within 24 hours had significantly lower multiorgan dysfunction scores and reduced rates of respiratory failure.
Additionally, patients treated with TCZ exhibited lower 30-day and in-hospital mortality rates, highlighting its benefits in critical COVID-19 care.

View Article and Find Full Text PDF

Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study.

Hakeam A Hakeam Ghadi Askar Khalid Al Sulaiman Reem Mansour Maha M Al Qahtani

J Infect Public Health

October 2022

Ceftolozane-tazobactam is an emerging ‎treatment for severe infections caused by multidrug-resistant (MDR) Pseudomonas ‎aeruginosa. However, limited ‎data support its use in bacteremia treatment. This study aimed to assess the effectiveness of the treatment of MDR P.

View Article and Find Full Text PDF